Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-15

Clinical Trial Update: Study of Blood Concentrations and Physiologic Effects of Levosimendan Given During Heart Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial of levosimendan given during heart surgery was terminated; the update discusses blood concentrations and physiologic effects in patients with hear…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levosimendan (levosimendan)

Snippet

Sponsor: Emory University | Conditions: Heart Failure | Phase 3 | Status: TERMINATED